SCHEMBL28895219

SCHEMBL28895219

CC(C)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OP(=O)(O)O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP46A1 Q9Y6A2 2/20 0.75
POLA1 P09884 1/20 0.74
OSBP P22059 4/20 0.71
RORC P51449 3/20 0.71
USP2 O75604 2/20 0.71
OSBP2 Q969R2 2/20 0.71
LMNA P02545 1/20 0.71
ABCB1 P08183 1/20 0.71
NR1H3 Q13133 3/20 0.62
GRIN1 Q05586 2/20 0.61
GRIN2A Q12879 2/20 0.61
GBA1 P04062 2/20 0.60
UGCG Q16739 2/20 0.60
GBA2 Q9HCG7 2/20 0.60
NPC1L1 Q9UHC9 4/20 0.59
PLA2G2A P14555 1/20 0.59
CRYAB P02511 1/20 0.58
HMGCR P04035 1/20 0.58
ITGB3 P05106 1/20 0.58
ITGAV P06756 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL593421 1.00 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL27320611 1.00 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL349479 1.00 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL349478 1.00 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL21879230 0.99 CYP46A1 (0.74) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL15174782 0.99 CYP46A1 (0.74) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL27762145 0.99 CYP46A1 (0.74) CYP46A1POLA1OSBPRORCUSP2
Dimethyl Sulfoxide SCHEMBL9614562 0.96 CYP46A1 (0.70) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL14174362 0.94 CYP46A1 (0.74) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL28419590 0.93 CYP46A1 (0.71) CYP46A1POLA1OSBPRORCUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117015400-A Treatment of diseases associated with ATP-binding cassette transporter 1 dysfunction using TREM2 agonists 维吉尔神经科学股份有限公司 2023-11-07 CN claimed
CN-116964454-A Treatment of diseases associated with colony stimulating factor 1 receptor dysfunction using TREM2 agonists 维吉尔神经科学股份有限公司 2023-10-27 CN claimed
CN-111448212-A anti-TREM 2 antibodies and methods of use thereof 戴纳立制药公司 2020-07-24 CN claimed
CN-118103398-A TREM2 agonist biomarkers and methods of use thereof 维吉尔神经科学公司 2024-05-28 CN disclosed
CN-117015400-A Treatment of diseases associated with ATP-binding cassette transporter 1 dysfunction using TREM2 agonists 维吉尔神经科学股份有限公司 2023-11-07 CN disclosed
CN-116964454-A Treatment of diseases associated with colony stimulating factor 1 receptor dysfunction using TREM2 agonists 维吉尔神经科学股份有限公司 2023-10-27 CN disclosed
CN-115279790-A anti-TREM 2 antibodies and methods of use thereof 戴纳立制药公司 2022-11-01 CN disclosed
CN-113614110-A anti-TREM 2 antibodies and methods of use thereof 戴纳立制药公司 2021-11-05 CN disclosed